<?xml version="1.0" encoding="UTF-8"?>
<p class="p">To study the effect of increased solubility and the improved release rate of EPL from the prepared NE liquisolid formulation on drug absorption and bioavailability, the optimized formulation (F4) was compared to the corresponding EPL-NE and conventional oral tablets in rabbit bioavailability studies. The mean pharmacokinetic parameters of EPL of different tested formulations are summarized in 
 <xref rid="pharmaceutics-11-00040-t004" ref-type="table" class="xref">Table 4</xref> and the mean plasma concentration-time profiles are illustrated in 
 <xref ref-type="fig" rid="pharmaceutics-11-00040-f005" class="xref">Figure 5</xref>.
</p>
